NewsOtonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
ResearchIntratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
NewsOtonomy Now Recruiting Participants for Phase 2 Study of OTO-313 in Tinnitus [Update: New Locations Added]
NewsOtonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 in Patients with Tinnitus
NewsOtonomy Provides Update on Clinical Trials: Results from Phase 1/2 trial of OTO-313 for tinnitus expected in July 2020
NewsPhase 1/2 clinical trial of OTO-313 (single intratympanic injection) in patients with subjective tinnitus is now recruiting
NewsOtonomy Initiates Phase 1/2 Clinical Trial to evaluate the therapeutic potential of OTO-313 in patients with tinnitus
